Recombinant human serum albumin

Drugs of Today

Volumn 43, Issue 8, 2007, Pages 547-561

  Chuang, Victor T G ^a   Otagiri, Masaki ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBREC; AMINOPTERIN; DIAZEPAM; DIURETIC AGENT; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; FUROSEMIDE; GB 1057; HUMAN SERUM ALBUMIN; IBUPROFEN; METHOTREXATE; PACLITAXEL; PHENPROCOUMON; PLASMA SUBSTITUTE; PRANOPROFEN; RECOMBINANT HUMAN SERUM ALBUMIN; SALICYLIC ACID; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; WARFARIN;

ANTIGENICITY; ASCITES; BACTERIAL PERITONITIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; CRYSTAL STRUCTURE; CULTURE MEDIUM; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DRUG BINDING; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MANUFACTURE; DRUG PROTEIN BINDING; DRUG PURIFICATION; DRUG SAFETY; DRUG STRUCTURE; GENE EXPRESSION SYSTEM; HEMORRHAGIC SHOCK; HUMAN; LIVER CIRRHOSIS; MATERIAL COATING; NONHUMAN; ONCOTIC PRESSURE; PLASMA VOLUME; REVIEW; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; VIRAL CONTAMINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONTROLLED CLINICAL TRIALS AS TOPIC; DRUG CARRIERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SERUM ALBUMIN;

EID: 34948884120     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2007.43.8.1067343     Document Type: Review

References (100)

1. Kobayashi, K. Summary of recombinant human serum albumin development. Biologicals 2006, 34: 55-9.
2. Kobayashi, K., Nakamura, N., Sumi, A., Ohmura, T., Yokoyama, K. The development of recombinant human serum albumin. Ther Apher 1998, 2: 257-62.
3. Lawn, R.M., Adelman, J., Bock, S.C. et al. The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res 1981, 9: 6103-14.
4. Saunders, C.W., Schmidt, B.J., Mallonee, R.L., Guyer, M.S. Secretion of human serum albumin from Bacillus subtilis. J Bacteriol 1987, 169: 2917-25.
5. Quirk, A.V., Geisow, M.J., Woodrow, J.R. et al. Production of recombinant human serum albumin from Saccharomyces cerevisiae. Biotechnol Appl Biochem 1989, 11: 273-87.
6. Sleep, D., Belfield, G.P., Goodey, A.R. The secretion of human serum albumin from the yeast Saccharomyces cerevisiae using five different leader sequences. Biotechnology (NY) 1990, 8: 42-6.
7. Ohi, H., Miura, M., Hiramatsu, R., Ohmura, T. The positive and negative cis-acting elements for methanol regulation in the Pichia pastoris AOX2 gene. Mol Gen Genet 1994, 243: 489-99.
8. Ohi, H., Okazaki, N., Uno, S., Miura, M., Hiramatsu, R. Chromosomal DNA patterns and gene stability of Pichia pastoris. Yeast 1998, 14: 895-903.
9. Kobayashi, K., Kuwae, S., Ohya, T. et al. High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. J Biosci Bioeng 2000, 89: 55-61.
10. Blondeau, K., Boze, H., Jung, G., Moulin, G., Galzy, P. Physiological approach to heterologous human serum albumin production by Kluyveromyces lactis in chemostat culture. Yeast 1994, 10: 1297-303.
11. Fleer, R., Yeh, P., Amellal, N. et al. Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Biotechnology (NY) 1991, 9: 968-75.
12. Kang, H.A., Kang, W., Hong, W.K. et al. Development of expression systems for the production of recombinant human serum albumin using the MOX promoter in Hansenula polymorpha DL-1. Biotechnol Bioeng 2001, 76: 175-85.
13. Sijmons, P.C., Dekker, B.M., Schrammeijer, B., Verwoerd, T.C., van den Elzen, P.J., Hoekema, A. Production of correctly processed human serum albumin in transgenic plants. Biotechnology (NY) 1990, 8: 217-21.
14. Barash, I., Faerman, A., Ratovitsky, T. et al. Ectopic expression of beta-lactoglobulin/human serum albumin fusion genes in transgenic mice: Hormonal regulation and in situ localization. Transgenic Res 1994, 3: 141-51.
15. Hurwitz, D.R., Nathan, M., Barash, I., Ilan, N., Shani, M. Specific combinations of human serum albumin introns direct high-level expression of albumin in transfected COS cells and in the milk of transgenic mice. Transgenic Res 1994, 3: 365-75.
16. Farran, I., Sanchez-Serrano, J.J., Medina, J.F., Prieto, J., Mingo-Castel, A.M. Targeted expression of human serum albumin to potato tubers. Transgenic Res 2002, 11: 337-46.
17. Huang, L.F., Liu, Y.K., Lu, C.A., Hsieh, S.L., Yu, S.M. Production of human serum albumin by sugar starvation induced promoter and rice cell culture. Transgenic Res 2005, 14: 569-81.
18. Kobayashi, K., Kuwae, S., Ohya, T., Ohda, T., Ohyama, M., Tomomitsu, K. High-level secretion of recombinant human serum albumin by fed-batch fermentation of the methylotrophic yeast, Pichia pastoris, based on optimal methanol feeding strategy. J Biosci Bioeng 2000, 90: 280-8.
19. Ohya, T., Ohyama, M., Kobayashi, K. Optimization of human serum albumin production in methylotrophic yeast Pichia pastoris by repeated fed-batch fermentation. Biotechnol Bioeng 2005, 90: 876-87.
20. Kobayashi, K., Kuwae, S., Ohya, T., Ohda, T., Ohyama, M., Tomomitsu, K. Addition of oleic acid increases expression of recombinant hu man serum albumin by the AOX2 promoter in Pichia pastoris. J Biosci Bioeng 2000, 89: 479-84.
21. Sumi, A., Okuyama, K., Kobayashi, K., Ohtani, W., Ohmura, T., Yokoyama, K. Purification of recombinant human serum albumin efficient purification using Streamline. Bioseparation 1999, 8: 195-200.
22. Ohtani, W., Ohda, T., Sumi, A., Kobayashi, K., Ohmura, T. Analysis of Pichia pastoris components in recombinant human serum albumin by immunological assays and by HPLC with pulsed amperometric detection. Anal Chem 1998, 70: 425-9.
23. Ikegaya, K., Hirose, M., Ohmura, T., Nokihara, K. Complete determination of disulfide forms of purified recombinant human serum albumin, secreted by the yeast Pichia pastoris. Anal Chem 1997, 69: 1986-91.
24. Ohtani, W., Masaki, A., Ikeda, Y. et al. Structure of recombinant human serum albumin from Pichia pastoris. Yakugaku Zasshi 1997, 117: 220-32.
25. Watanabe, H., Yamasaki, K., Kragh-Hansen, U. et al. In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharm Res 2001, 18: 1775-81.
26. Chen, J., Anderson, J.B., DeWeese-Scott, C. et al. MMDB: Entrez's 3D-structure database. Nucleic Acids Res 2003, 31: 474-7.
27. Takeshima, K., Ohtani, W., Sumi, A., Ohmura, T. Ligand binding properties and esterase-like activity of recombinant human serum albumin. Yakugaku Zasshi 1996, 116: 622-9.
28. Bosse, D., Praus, M., Kiessling, P. et al. Phase I comparability of recombinant human albumin and human serum albumin. J Clin Pharmacol 2005, 45: 57-67.
29. Higashi, J., Yamamoto, I., Aoki, T., Hashida, S., Tokuda, K., Toda, Y. Phase I clinical trial of GB-1057 (Human Serum albumin (Recombinant)). Rinsho to Kenkyu 1997, 2841-55.
30. Ota, M., Yamamoto, Y., Terada, H., Otomo, Y., Yuasa, S. Phase II clinical trial of GB-1057 (Human Serum albumin (Recombinant)) in patients with hemorrhagic shock. Evaluation of the efficacy and safety of the 5% dosage form. Rinsho to Kenkyu 1997, 2874-83.
31. Kamata, T., Toda, K., Kasahara, A., Uematsu, M., Yuasa, S. Phase II clinical trial of GB-1057 (Human Serum albumin (Recombinant)) in patients with cirrhosis and ascites. Rinsho to Kenkyu 1997, 2856-73.
32. Kamata, T., Toda, K., Kasahara, A., Uematsu, M., Hanaoka, K., Yuasa, S. Multicenter phase II clinical trial on the comparability of GB-1057 (Human Serum albumin (Recombinant)) and plasma-derived human serum albumin in patients with cirrhosis and ascites. Rinsho to Kenkyu 1997, 2884-99.
33. Koshikawa, S., Ota, Z., Ideura, T., Makino, H., Yoshimura, A., Yuasa, S. A study on the efficacy and safety of repeated dosing of GB-1057 (Human Serum albumin (Recombinant)) in patients with nephritic syndrome and edema. Rinsho to Kenkyu 1997, 3138-48.
34. Kamata, T., Toda, K., Kasahara, A., Uematsu, M., Yuasa, S. A study on repeated dosing of GB-1057 (Human Serum albumin (Recombinant)) in patients with cirrhosis and ascites. Rinsho to Kenkyu 1997, 3128-37.
35. Ota, M., Yamamoto, Y., Terada, H., Otomo, Y., Yuasa, S. General clinical trial of GB-1057 (Human Serum albumin (Recombinant)) for hemorrhagic shock. Evaluation of the efficacy and safety of the 25% dosage form. Rinsho to Kenkyu 1997, 74: 2916-27.
36. Koshikawa, S., Ota, Z., Ideura, T., Makino, H., Yoshimura, A., Yuasa, S. General clinical trial on the efficacy and safety of GB-1057 (Human Serum albumin (Recombinant)) in patients with nephritic syndrome and edema. Rinsho to Kenkyu 1997, 74: 2900-15.
37. Ota, M., Yamamoto, Y., Terada, H., Otomo, Y., Yuasa, S. General clinical trial of GB-1057 (Human Serum albumin (Recombinant)) in patients with burn injury. Rinsho to Kenkyu 1997, 74: 2928-39.
38. Motoki, R., Inoue, H., Kogure, M. et al. General clinical trial of GB-1057 (Human Serum albumin (Recombinant)) in patients after major surgery. Rinsho to Kenkyu 1997, 74: 3162-77.
39. Koyanagi, H., Hatta, M., Hirata, K., Yuasa, S. General clinical trial of GB-1057 (Human Serum albumin (Recombinant)) for hypoalbuminemia after open heart surgery. Rinsho to Kenkyu 1997, 74: 3196-208.
40. Yagi, M., Hashimoto, T., Kojima, Y. et al. General clinical trial of GB-1057 (Human Serum albumin (Recombinant)) for poor risk cases. Rinsho to Kenkyu 1997, 74: 3178-95.
41. Chuang, V.T., Kragh-Hansen, U., Otagiri, M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 2002, 19: 569-77.
42. Alderson, P., Bunn, F., Lefebvre, C. et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004, CD001208.
43. Finfer, S., Bellomo, R., Boyce, N., French, J., Myburgh, J., Norton, R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350: 2247-56.
44. Finfer, S., Bellomo, R., McEvoy, S. et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: Analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 2006, 333: 1044.
45. Wong, F. Drug insight: The role of albumin in the management of chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2007, 4: 43-51.
46. Cochran, A., Morris, S.E., Edelman, L.S., Saffle, J.R. Burn patient characteristics and outcomes following resuscitation with albumin. Burns 2007, 33: 25-30.
47. Shimmura, S., Ueno, R., Matsumoto, Y. et al. Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol 2003, 87: 1279-83.
48. Cha, M.K., Kim, I.H. Glutathione-linked thiol peroxidase activity of human serum albumin: A possible antioxidant role of serum albumin in blood plasma. Biochem Biophys Res Commun 1996, 222: 619-25.
49. Armstrong, J.S., Rajasekaran, M., Hellstrom, W.J., Sikka, S.C. Antioxidant potential of human serum albumin: Role in the recovery of high-quality human spermatozoa for assisted reproductive technology. J Androl 1998, 19: 412-9.
50. Kaden, R., Klippel, F.F., Katzorke, T., Propping, D., Schone, D. A new instant cryoprotectant for human sperm. Arch Androl 1985, 14: 133-7.
51. Hovatta, O. Methods for cryopreservation of human ovarian tissue. Reprod Biomed Online 2005, 10: 729-34.
52. Meyer, T.P., Hofmann, B., Zaisserer, J. et al. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Cytotherapy 2006, 8: 265-76.
53. Lane, M., Maybach, J.M., Hooper, K., Hasler, J.F., Gardner, D.K. Cryo-survival and development of bovine blastocysts are enhanced by culture with recombinant albumin and hyaluronan. Mol Reprod Dev 2003, 64: 70-8.
54. Lee, E.J., Lee, S.A., Kim, J. The effect of human serum albumin on the extended storage of human oral keratinocyte viability under mild hypothermia. Cryobiology 2005, 50: 103-11.
55. Brown, J.S., Ledoux, R., Nelson, H.S. An investigation of possible immunologic reactions to human serum albumin used as a stabilizer in allergy extracts. J Allergy Clin Immunol 1985, 76: 808-12.
56. Tarelli, E., Mire-Sluis, A., Tivnann, H.A. et al. Recombinant human albumin as a stabilizer for biological materials and for the preparation of international reference reagents. Biologicals 1998, 26: 331-46.
57. Wosikowski, K., Biedermann, E., Rattel, B. et al. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin Cancer Res 2003, 9: 1917-26.
58. Dosio, F., Arpicco, S., Brusa, P., Stella, B., Cattel, L. Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: Preparation, characterization and pharmacokinetics. J Control Release 2001, 76: 107-17.
59. Stehle, G., Wunder, A., Schrenk, H.H., Hartung, G., Heene, D.L., Sinn, H. Albumin-based drug carriers: Comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate. Anticancer Drugs 1999, 10: 785-90.
60. Cai, C., Zhou, K., Wu, Y., Wu, L. Enhanced liver targeting of 5-fluorouracil using galactosylated human serum albumin as a carrier molecule. J Drug Target 2006, 14: 55-61.
61. Di Stefano, G., Fiume, L., Baglioni, M. et al. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade. Liver Int 2006, 26: 726-33.
62. Di Stefano, G., Lanza, M., Kratz, F., Merina, L., Fiume, L. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: Synthesis, characterization and preliminary biological properties of the conjugate. Eur J Pharm Sci 2004, 23: 393-7.
63. Di Stefano, G., Tubaro, M., Lanza, M., Boga, C., Fiume, L., Traldi, P. Synthesis and physicochemical characteristics of a liver-targeted conjugate of fluorodeoxyuridine monophosphate with lactosaminated human albumin. Rapid Commun Mass Spectrom 2003, 17: 2503-7.
64. Kremer, P., Hartung, G., Bauder-Wust, U. et al. Efficacy and tolerability of an aminopterin-albumin conjugate in tumor-bearing rats. Anticancer Drugs 2002, 13: 615-23.
65. Thibaudeau, K., Leger, R., Huang, X. et al. Synthesis and evaluation of insulin-human serum albumin conjugates. Bioconjug Chem 2005, 16: 1000-8.
66. Shechter, Y., Mironchik, M., Rubinraut, S., Saul, A., Tsubery, H., Fridkin, M. Albumin-insulin conjugate releasing insulin slowly under physiological conditions: A new concept for long-acting insulin. Bioconjug Chem 2005, 16: 913-20.
67. Wartlick, H., Spankuch-Schmitt, B., Strebhardt, K., Kreuter, J., Langer, K. Tumour cell delivery of antisense oligonucleotides by human serum albumin nanoparticles. J Control Release 2004, 96: 483-95.
68. Sharma, R.I., Pereira, M., Schwarzbauer, J.E., Moghe, P.V. Albumin-derived nanocarriers: Substrates for enhanced cell adhesive ligand display and cell motility. Biomaterials 2006, 27: 3589-98.
69. Sakai, H., Masada, Y., Horinouchi, H. et al. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 2004, 32: 539-45.
70. Komatsu, T., Hamamatsu, K., Takeoka, S., Nishide, H., Tsuchida, E. Human serum albumin-bound synthetic hemes as an oxygen carrier: Determination of equilibrium constants for heme binding to host albumin. Artif Cells Blood Substit Immobil Biotechnol 1998, 26: 519-27.
71. Komatsu, T., Hamamatsu, K., Wu, J., Tsuchida, E. Physicochemical properties and O2-coordination structure of human serum albumin incorporating tetrakis(o-pivalamido)-phenylporphyrinatoiron(II) derivatives. Bioconjug Chem 1999, 10: 82-6.
72. Tsuchida, E., Komatsu, T., Matsukawa, Y., Hamamatsu, K., Wu, J. Human serum albumin incorporating Tetrakis(o-pivalamido) phenylporphinatoiron(II) derivative as a totally syn thetic O2-carrying hemoprotein. Bioconjug Chem 1999, 10: 797-802.
73. Komatsu, T., Matsukawa, Y., Tsuchida, E. Kinetics of CO and O(2) binding to human serum albumin-heme hybrid. Bioconjug Chem 2000, 11: 772-6.
74. Kobayashi, K., Komatsu, T., Iwamaru, A. et al. Oxygenation of hypoxic region in solid tumor by administration of human serum albumin incorporating synthetic hemes. J Biomed Mater Res A 2003, 64: 48-51.
75. Tsuchida, E., Komatsu, T., Matsukawa, Y. et al. Human serum albumin incorporating synthetic heme: Red blood cell substitute without hypertension by nitric oxide scavenging. J Biomed Mater Res A 2003, 64: 257-61.
76. Nakagawa, A., Komatsu, T., Iizuka, M., Tsuchida, E. Human serum albumin hybrid incorporating tailed porphyrinatoiron(II) in the alpha,alpha,alpha,beta-conformer as an O2-binding site. Bioconjug Chem 2006, 17: 146-51.
77. Matsushita, S., Isima, Y., Chuang, V.T. et al. Functional analysis of recombinant human serum albumin domains for pharmaceutical applications. Pharm Res 2004, 21: 1924-32.
78. Matsushita, S., Chuang, V.T., Kanazawa, M. et al. Recombinant human serum albumin dimer has high blood circulation activity and low vascular permeability in comparison with native human serum albumin. Pharm Res 2006, 23: 882-91.
79. Ishima, Y., Akaike, T., Kragh-Hansen, U. et al. S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial and cytoprotective properties. J Pharmacol Exp Ther 2007, 320: 969-77.
80. Benjamin, P.P. A rapid and efficient method of preparing 99mTc-human serum albumin: Its clinical applications. Int J Appl Radiat Isot 1969, 20: 187-94.
81. Callahan, R.J., McKusick, K.A., Lamson, M. 3rd, Castronovo, F.P., Potsaid, M.S. Technetium-99m-human serum albumin: Evaluation of a commercially produced kit. J Nucl Med 1976, 17: 47-9.
82. Hara, M., Kayamori, R., Sato, K., Tamura, K., Washio, M. Cardiac pool scintigraphy with 99mTc-human serum albumin. Rinsho Hoshasen 1976, 21: 35-40.
83. Ito, K., Kobayashi, S., Hisada, K., Ando, A., Tonami, N. Study on tumor affinity of tech netium-99m-labeled radiopharmaceuticals. (1) 99mTc-pertechnetate, 99mTc-human serum albumin, and 99mTc-trasylol. Radioisotopes 1976, 25: 614-21.
84. Porter, W.C., Dworkin, H.J., Gutkowski, R.F. The effect of carrier technetium in the preparation of 99mTc-human serum albumin. J Nucl Med 1976, 17: 704-6.
85. Matsuo, M., Uehara, T., Yoshimoto, S. et al. A comparative study, by objective quantization using microdensitometry, between cardiac pool images obtained using red blood cells labeled in vivo with 99mTc and using 99mTc-human serum albumin (author's transl.) Radioisotopes 1979, 28: 500-5.
86. Perkins, A.C., Frier, M. Experimental biodistribution studies of 99mTc-recombinant human serum albumin (rHSA): A new generation of radiopharmaceutical. Eur J Nucl Med 1994, 21: 1231-3.
87. Edenbrandt, C.M., Andersson, L., Larsson, I. et al. Diagnosis of deep venous thrombosis by 99mTc-human serum albumin microcolloid. Eur J Nucl Med 1983, 8: 332-4.
88. Halaby, H., Bakheet, S.M., Shabib, S., Powe, J.E., Al Mehaidib, A., Nazer, H. 99mTc-human serum albumin scans in children with protein-losing enteropathy. J Nucl Med 2000, 41: 215-9.
89. Kinuya, S., Taki, J., Nakajima, K. et al. Inguinoscrotal lymphatic reflux detected by lymphoscintigraphy. Ann Nucl Med 1996, 10: 351-2.
90. Bedrosian, I., Scheff, A.M., Mick, R. et al. 99mTc-human serum albumin: An effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med 1999, 40: 1143-8.
91. Schuh-Hofer, S., Richter, M., Israel, H. et al. The use of radiolabeled human serum albumin and SPECT/MRI co-registration to study inflammation in the cavernous sinus of cluster headache patients. Cephalalgia 2006, 26: 1115-22.
92. Ozawa, T., Kimura, K., Koyanagi, Y. et al. First-pass effect by infusing 99mTc-human serum albumin into the hepatic artery. Gan To Kagaku Ryoho 1988, 15: 2479-83.
93. Verbrugge, S.J., Gommers, D., Bos, J.A. et al. Pulmonary 99mTc-human serum albumin clearance and effects of surfactant replacement after lung lavage in rabbits. Crit Care Med 1996, 24: 1518-23.
94. Hwang, E.H., Taki, J., Shuke, N. et al. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999, 40: 1644-51.
95. Okizaki, A., Shuke, N., Yamamoto, W. et al. Protein-loss into retroperitoneal lymphangioma: Demonstration by lymphoscintigraphy and blood-pool scintigraphy with Tc-99m-human serum albumin. Ann Nucl Med 2000, 14: 131-4.
96. Ichioka, T., Miyatake, S., Asai, N. et al. Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate. J Neurooncol 2004, 67: 47-52.
97. Park, H.S., Lee, S.K., Kim, H.Y., Nahm, D.H., Kim, S.S. Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: Useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. Clin Exp Allergy 2002, 32: 551-5.
98. Brynda, E., Houska, M., Jirouskova, M., Dyr, J.E. Albumin and heparin multilayer coatings for blood-contacting medical devices. J Biomed Mater Res 2000, 51: 249-57.
99. Sperling, C., Houska, M., Brynda, E., Streller, U., Werner, C. In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique. J Biomed Mater Res A 2006, 76: 681-9.
100. Magoshi, T., Matsuda, T. Formation of polymerized mixed heparin/albumin surface layer and cellular adhesional responses. Biomacromolecules 2002, 3: 976-83.